KPV 30mg

Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided.

For research use only — not for human or veterinary use.

Product Overview

KPV is a synthetic tripeptide derived from the C-terminal sequence of alpha-melanocyte-stimulating hormone (α-MSH). It is studied in controlled laboratory environments for its role in inflammatory-pathway modulation, immune signalling research and peptide-mediated regulatory mechanisms. This 30 mg preparation is supplied as a lyophilized powder in a sealed 3 ml research vial and is intended exclusively for in vitro research applications.

Peptide Overview

KPV consists of a short amino acid sequence that has been incorporated into research models investigating peptide-based regulation of inflammatory signalling and immune-related biochemical pathways. Due to its minimal structure and stability profile, KPV is frequently utilised in laboratory studies examining cellular response modulation and peptide–receptor interaction dynamics.

Historical Background and Scientific Context

Research into melanocortin-derived peptides expanded during the late twentieth century as laboratories explored endogenous regulatory mechanisms involved in inflammation and immune balance. Short-chain peptides such as KPV have since been used in preclinical research frameworks as reference compounds for studying peptide-mediated modulation within controlled biochemical systems.

Mechanistic Focus in Research

• Inflammatory-pathway and cytokine signalling research
• Immune-regulatory peptide interaction studies
• Cellular response modulation modelling
• Comparative structure–function evaluation
• Controlled in vitro biochemical investigations

Analytical and Manufacturing Notes

This KPV preparation is supplied as a lyophilized powder and is engineered to exceed 99 percent purity based on controlled synthesis protocols and internal quality benchmarks. Independent third-party analytical verification may be provided separately when available.

Research Applications

• Inflammatory and immune signalling research
• Peptide-mediated regulatory pathway modelling
• Cellular response and cytokine interaction studies
• Comparative anti-inflammatory peptide evaluation
• Controlled in vitro laboratory investigations

Grail Formula Quality

Grail Formula research peptides are produced under controlled synthesis conditions with a focus on purity, consistency and reproducibility. Each formulation is designed to support reliable laboratory research and mechanistic investigation.

When You Choose Grail Formula…

Researchers receive sealed research vials with documented handling procedures and batch identification. EU shipments include sterile bacteriostatic water; outside the EU only the peptide vial is supplied.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment or investigation
• Supplied to another party for human investigational use

Engineered to exceed 99 percent purity
Lyophilized KPV supplied in a sealed 3 ml vial
Short-chain anti-inflammatory research peptide
Designed for immune and inflammatory pathway research
Produced under controlled synthesis conditions
High batch-to-batch consistency
EU shipments include bacteriostatic water
For research use only — not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.